Evidence map›Paper›PMID 32593318›Full record

SynthesisThe Lancet. Infectious diseases2020

Clinical and epidemiological performance of WHO Ebola case definitions: a systematic review and meta-analysis.

Grazia Caleo, Foivi Theocharaki, Kamalini Lokuge, Helen A Weiss, Leena Inamdar, Francesco Grandesso, Kostas Danis, Biagio Pedalino, Gary Kobinger, Armand Sprecher and 2 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The Lancet. Infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. The Ebola virus - going beyond the bleeding edge.Journal of medical microbiology · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Evaluating case definitions for Ebola virus disease.The Lancet. Infectious diseases · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Grazia CaleoManson Unit, Médecins sans Frontières, London, UK; MRC Tropical Epidemiology Group, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK. Electronic address: grazia.caleo@london.msf.org.
Foivi TheocharakiCentre for Longitudinal Studies, University College London, London, UK.
Kamalini LokugeManson Unit, Médecins sans Frontières, London, UK; National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, Canberra, ACT, Australia.
Helen A WeissMRC Tropical Epidemiology Group, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Leena InamdarPublic Health England, Leeds, UK.
Francesco GrandessoEpicentre, Paris, France.
Kostas DanisSanté Publique France, Saint-Maurice, France.
Biagio PedalinoTEPHINET, Task Force for Global Health, Decatur, GA, USA; Istituto Superiore Di Sanita, Rome, Italy.
Gary KobingerDépartement de Microbiologie-Infectiologie et d'Immunologie, Université Laval, Quebec City, QC, Canada.
Armand SprecherMédecins sans Frontières, Brussels, Belgium.
Jane GreigManson Unit, Médecins sans Frontières, London, UK.
Gian Luca Di TannaThe George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEbola virus disease case definition is a crucial surveillance tool to detect suspected cases for referral and as a screening tool for clinicians to support admission and laboratory testing decisions at Ebola health facilities. We aimed to assess the performance of the WHO Ebola virus disease case definitions and other screening scores.

methodsIn this systematic review and meta-analysis, we searched PubMed, Scopus, Embase, and Web of Science for studies published in English between June 13, 1978, and Jan 14, 2020. We included studies that estimated the sensitivity and specificity of WHO Ebola virus disease case definitions, clinical and epidemiological characteristics (symptoms at admission and contact history), and predictive risk scores against the reference standard (laboratory-confirmed Ebola virus disease). Summary estimates of sensitivity and specificity were calculated using bivariate and hierarchical summary receiver operating characteristic (when four or more studies provided data) or random-effects meta-analysis (fewer than four studies provided data).

findingsWe identified 2493 publications, of which 14 studies from four countries (Sierra Leone, Guinea, Liberia, and Angola) were included in the analysis. 12 021 people with suspected disease were included, of whom 4874 were confirmed as positive for Ebola virus infection. Six studies explored the performance of WHO case definitions in non-paediatric populations, and in all of these studies, suspected and probable cases were combined and could not be disaggregated for analysis. The pooled sensitivity of the WHO Ebola virus disease case definitions from these studies was 81·5% (95% CI 74·1-87·2) and pooled specificity was 35·7% (28·5-43·6). History of contact or epidemiological link was a key predictor for the WHO case definitions (seven studies) and for risk scores (six studies). The most sensitive symptom was intense fatigue (79·0% [95% CI 74·4-83·0]), assessed in seven studies, and the least sensitive symptom was pain behind the eyes (1·0% [0·0-7·0]), assessed in three studies. The performance of fever as a symptom varied depending on the cutoff used to define fever.

interpretationWHO Ebola virus disease case definitions perform suboptimally to identify cases at both community level and during triage at Ebola health facilities. Inclusion of intense fatigue as a key symptom and contact history could improve the performance of case definitions, but implementation of these changes will require effective collaboration with, and trust of, affected communities.

fundingMédecins sans Frontières.

Indexed as

Diagnostic Techniques and ProceduresDisease OutbreaksEbolavirusEpidemiological MonitoringAdolescentAdultAgedAged, 80 and overAngolaChildChild, PreschoolDiarrheaFatigueFemaleFeverGuinea

Identifiers

PMID32593318
PMCPMC9355392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.